choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Atacand

Atacand Newsletter
  • ANI Pharmaceuticals, inc (ANIP) Q2 2021 Earnings Call Transcript 06 Aug 2021 18:31 GMT

    … refiled our supplemental New Drug Application, or sNDA, to … by decreased revenues of Atacand and Arimidex. Contract manufacturing … to bring high-quality pharmaceutical solutions to patients, physicians … shareholders and bringing important medicines to the patients in need …

  • Medical Compass: Elevated blood pressure – Should you be concerned? 06 Jun 2021 03:00 GMT

    … responsible for guidelines on the treatment of hypertension, are lifestyle modifications … when medication is used, due to side effects. For example, the Trial … hypotensive agent, the blood pressure drug Atacand (candesartan) to treat prehypertensive patients …

  • Drugs for tapeworm, vertigo among possible COVID-19 treatments 26 Jan 2021 04:34 GMT

    trials to investigate repurposing existing medications to treat COVID-19 It includes drugstreatments help us get better if we do. Australian doctors … like candesartan (Atacand), irbesartan, … treatment.(Supplied)South Korean firm Daewoong Pharmaceutical

  • AstraZeneca sells drug rights for $400 million 04 Jan 2021 07:46 GMT

    … rights to the Atacand drug for hypertension management to German pharmaceutical company Cheplapharm … $400 million. The British-Swedish pharmaceutical major said it has already …

  • AstraZeneca concludes sale of Atacand 04 Jan 2021 18:36 GMT

    … over 70 countries to German pharmaceutical company Cheplapharm Arzneimittel GmbH. AstraZeneca … the agreement. Atacand is a prescription medicine approved for the treatment of heart …

  • AstraZeneca completes sale of rights to hypertension drugs to Cheplapharm 04 Jan 2021 07:33 GMT

    StockMarketWire.com - Pharmaceutical giant AstraZeneca said it had … commercial rights to its hypertension medications Atacand and Atacand Plus in over 70 …

  • ANI Pharmaceuticals, Inc.'s (ANIP) CEO Nikhil Lalwani on Q3 2020 Results - Earnings Call Transcript 08 Nov 2020 10:27 GMT

    … Wilson, Investor Relations for ANI Pharmaceuticals. Please go ahead. Lisa … that we continue to supply medicines to patients. Let me … intricacies of the supplemental New Drug Application or sNDA. Based … a decline in revenues of Atacand. Our cost of sales, …

  • AstraZeneca divests Atacand for USD400m 30 Oct 2020 17:05 GMT

    … Friday. Atacand is a prescription medicine approved for the treatment of heart … while Atacand Plus is approved for the treatment of hypertension. German pharmaceutical company … supply Atacand and Atacand Plus and will continue to commercialise the medicine

  • AstraZeneca strikes £307m deal for heart and blood pressure medicines 30 Oct 2020 09:58 GMT

    … failure and blood pressure medicines to German pharmaceutical company Cheplapharm Arzneimittel GmbH … under the deal. Atacand is a prescription drug approved to treat heart … failure and hypertension, while Atacand Plus …

  • AstraZeneca sells right to heart failure, blood pressure drugs for $400 mln 30 Oct 2020 07:56 GMT

    … failure and blood pressure medicines to German pharmaceutical company Cheplapharm Arzneimittel GmbH … under the deal. Atacand is a prescription drug approved to treat heart … failure and hypertension, while Atacand Plus …

Satisfied with the content?

Continue to create your account.